In one paragraphArticle in Circulation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Fan LiDepartment of Cardiovascular Medicine, Physiology, and Biomedical Engineering, Center for Regenerative Biotherapeutics, Mayo Clinic Arizona, Scottsdale, AZ (F.L., Y.S., H.Q., A.Z., W.Z.).ORCID 0000-0002-4073-4493 Yura SonDepartment of Cardiovascular Medicine, Physiology, and Biomedical Engineering, Center for Regenerative Biotherapeutics, Mayo Clinic Arizona, Scottsdale, AZ (F.L., Y.S., H.Q., A.Z., W.Z.).
Huiliang QiuDepartment of Cardiovascular Medicine, Physiology, and Biomedical Engineering, Center for Regenerative Biotherapeutics, Mayo Clinic Arizona, Scottsdale, AZ (F.L., Y.S., H.Q., A.Z., W.Z.).ORCID 0000-0001-8625-8974 Andrew ZhangDepartment of Cardiovascular Medicine, Physiology, and Biomedical Engineering, Center for Regenerative Biotherapeutics, Mayo Clinic Arizona, Scottsdale, AZ (F.L., Y.S., H.Q., A.Z., W.Z.).ORCID 0009-0006-0254-9955 Hongyu QiuDepartment of Internal Medicine, College of Medicine-Phoenix, University of Arizona, Phoenix, AZ (H.Q.).
Wuqiang ZhuDepartment of Cardiovascular Medicine, Physiology, and Biomedical Engineering, Center for Regenerative Biotherapeutics, Mayo Clinic Arizona, Scottsdale, AZ (F.L., Y.S., H.Q., A.Z., W.Z.).ORCID 0000-0001-5217-7789 Funding
Cardiomyocyte Non-autonomous Factors and Cardiac Regeneration in Large MammalsR01HL156855 · NHLBI · MAYO CLINIC ARIZONA · PI Wuqiang Zhu · 2022 to 2026
$3.3MStrategies to Enhance Engineered Heart Tissue Based Myocardial RepairR01HL162747 · NHLBI · MAYO CLINIC ARIZONA · PI Jingwei Xie, Wuqiang Zhu · 2023 to 2026
$2.9MElectrically Conductive Stem Cell Derived MicroEngineered Heart Tissue for Regeneration of Injured MyocardiumR01HL172784 · NHLBI · MAYO CLINIC ARIZONA · PI Mehdi Nikkhah, Wuqiang Zhu · 2024 to 2026
$2.0MMyocardial Repair with a Novel Engineered Cardiac Muscle PatchR01HL142627 · NHLBI · MAYO CLINIC ARIZONA · PI ZHU, WUQIANG · 2019 to 2022
$1.7MProgrammed Cell Death 4 in Doxorubicin-Induced CardiotoxicityR01HL180393 · NHLBI · MAYO CLINIC ARIZONA · PI Shu Wang, Wuqiang Zhu · 2025 to 2026
$1.3MMyocardial Repair with a Novel Engineered Cardiac Muscle PatchR56HL142627 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ZHU, WUQIANG · 2018 to 2018
$371kNHLBI NIH HHS R01 HL142627NHLBI NIH HHS R01 HL156855NHLBI NIH HHS R01 HL162747NHLBI NIH HHS R01 HL172784NHLBI NIH HHS R01 HL180393NHLBI NIH HHS R56 HL142627
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
cardiac myocytecell cycleglucosephosphate dehydrogenaseheart
Identifiers
PMID42607118
PMCPMC13483306
What OpenQuestion holds
Textmetadata
Read underepoch 390